Home > News > Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
January 9th, 2007
Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
Mirus Bio Corporation announced today it has entered into a two year, multimillion dollar agreement with Pfizer Inc. to investigate and optimize gene silencing methods in animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to target and suppress the expression of genes of interest to Pfizer.
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014
Harris & Harris Group Reports Financial Statements as of June 30, 2014 August 10th, 2014
Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014
Graphene may be key to leap in supercapacitor performance August 20th, 2014
Newly-Developed Nanobiosensor Quickly Diagnoses Cancer August 20th, 2014
Ultrasonic Waves Applied in Production of Graphene Nanosheets August 20th, 2014